Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 2
1952 2
1954 1
1957 1
1963 3
1964 1
1965 3
1966 2
1967 5
1968 3
1969 1
1970 5
1971 4
1972 4
1973 3
1974 4
1975 19
1976 17
1977 26
1978 25
1979 30
1980 32
1981 33
1982 42
1983 49
1984 77
1985 67
1986 72
1987 65
1988 85
1989 83
1990 86
1991 103
1992 116
1993 120
1994 98
1995 131
1996 97
1997 124
1998 135
1999 117
2000 138
2001 141
2002 157
2003 150
2004 165
2005 226
2006 244
2007 250
2008 270
2009 276
2010 325
2011 347
2012 402
2013 489
2014 510
2015 588
2016 600
2017 654
2018 684
2019 733
2020 825
2021 947
2022 863
2023 833
2024 284

Text availability

Article attribute

Article type

Publication date

Search Results

11,437 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Pulmonary fibrosis and/or bone marrow failure, telomere-related, 6"
Page 1
Mechanisms of pulmonary fibrosis.
Thannickal VJ, Toews GB, White ES, Lynch JP 3rd, Martinez FJ. Thannickal VJ, et al. Annu Rev Med. 2004;55:395-417. doi: 10.1146/annurev.med.55.091902.103810. Annu Rev Med. 2004. PMID: 14746528 Free article. Review.
Significant regional heterogeneity, with varied histopathological patterns of inflammation and fibrosis, has been observed in individual patients with idiopathic pulmonary fibrosis. ...Better understanding of the mechanisms of lung repair, which includ …
Significant regional heterogeneity, with varied histopathological patterns of inflammation and fibrosis, has been observed in …
Presentation, diagnosis and clinical course of the spectrum of progressive-fibrosing interstitial lung diseases.
Cottin V, Hirani NA, Hotchkin DL, Nambiar AM, Ogura T, Otaola M, Skowasch D, Park JS, Poonyagariyagorn HK, Wuyts W, Wells AU. Cottin V, et al. Eur Respir Rev. 2018 Dec 21;27(150):180076. doi: 10.1183/16000617.0076-2018. Print 2018 Dec 31. Eur Respir Rev. 2018. PMID: 30578335 Free PMC article. Review.
Although these conditions are rare, a proportion of patients with interstitial lung diseases (ILDs) may develop a progressive-fibrosing phenotype. Progressive fibrosis is associated with worsening respiratory symptoms, lung function decline, limited response to immunomodul …
Although these conditions are rare, a proportion of patients with interstitial lung diseases (ILDs) may develop a progressive-fibrosing phen …
A multidimensional index and staging system for idiopathic pulmonary fibrosis.
Ley B, Ryerson CJ, Vittinghoff E, Ryu JH, Tomassetti S, Lee JS, Poletti V, Buccioli M, Elicker BM, Jones KD, King TE Jr, Collard HR. Ley B, et al. Ann Intern Med. 2012 May 15;156(10):684-91. doi: 10.7326/0003-4819-156-10-201205150-00004. Ann Intern Med. 2012. PMID: 22586007
BACKGROUND: Idiopathic pulmonary fibrosis (IPF) is a progressive fibrotic lung disease with an overall poor prognosis. ...A model using continuous predictors (GAP calculator) and a simple point-scoring system (GAP index) performed similarly in d …
BACKGROUND: Idiopathic pulmonary fibrosis (IPF) is a progressive fibrotic lung disease with an overall poor prognosis. ...A mo …
Pulmonary fibrosis.
Zisman DA, Keane MP, Belperio JA, Strieter RM, Lynch JP 3rd. Zisman DA, et al. Methods Mol Med. 2005;117:3-44. doi: 10.1385/1-59259-940-0:003. Methods Mol Med. 2005. PMID: 16130230 Free PMC article. Review.
Idiopathic pulmonary fibrosis (IPF) is a chronic fibrosing lung disease limited to the lungs and associated with the histologic appearance of usual interstitial pneumonia (UIP) on surgical lung biopsy. The estimated prevalence in the United States is between 35,000 …
Idiopathic pulmonary fibrosis (IPF) is a chronic fibrosing lung disease limited to the lungs and associated with the histologi …
Simple method of estimating severity of pulmonary fibrosis on a numerical scale.
Ashcroft T, Simpson JM, Timbrell V. Ashcroft T, et al. J Clin Pathol. 1988 Apr;41(4):467-70. doi: 10.1136/jcp.41.4.467. J Clin Pathol. 1988. PMID: 3366935 Free PMC article.
A continuous numerical scale for determining the degree of fibrosis in lung specimens was devised for correlation with other pulmonary variables such as lung function tests or mineral burden. Grading was scored on a scale from 0 to 8, using the average of microscope …
A continuous numerical scale for determining the degree of fibrosis in lung specimens was devised for correlation with other pulmo …
Sarcoidosis-associated pulmonary fibrosis: joining the dots.
Bandyopadhyay D, Mirsaeidi MS. Bandyopadhyay D, et al. Eur Respir Rev. 2023 Sep 27;32(169):230085. doi: 10.1183/16000617.0085-2023. Print 2023 Sep 30. Eur Respir Rev. 2023. PMID: 37758275 Free PMC article. Review.
A minority of patients with sarcoidosis develop sarcoidosis-associated pulmonary fibrosis (SAPF), which may become progressive. Genetic profiles differ between patients with progressive and self-limiting disease. ...The management of patients with SAPF should includ …
A minority of patients with sarcoidosis develop sarcoidosis-associated pulmonary fibrosis (SAPF), which may become progressive …
The Value and Application of the 6-Minute-Walk Test in Idiopathic Pulmonary Fibrosis.
Brown AW, Nathan SD. Brown AW, et al. Ann Am Thorac Soc. 2018 Jan;15(1):3-10. doi: 10.1513/AnnalsATS.201703-244FR. Ann Am Thorac Soc. 2018. PMID: 28933948 Review.
The 6-minute-walk test is a commonly used assessment of performance ability in a variety of cardiopulmonary diseases. ...The 6-minute-walk test distance has served as a primary endpoint in many drug trials, most notably in the field of pulmonary arterial hype …
The 6-minute-walk test is a commonly used assessment of performance ability in a variety of cardiopulmonary diseases. ...The 6 …
When to start and when to stop antifibrotic therapies.
Torrisi SE, Pavone M, Vancheri A, Vancheri C. Torrisi SE, et al. Eur Respir Rev. 2017 Oct 3;26(145):170053. doi: 10.1183/16000617.0053-2017. Print 2017 Sep 30. Eur Respir Rev. 2017. PMID: 28974541 Free PMC article. Review.
Idiopathic pulmonary fibrosis (IPF) is characterised by progressive changes of the lung architecture causing cough and dyspnoea and ultimately leading to lung failure and death. ...In IPF, particularly when the disease is diagnosed at an early stage, "wait an …
Idiopathic pulmonary fibrosis (IPF) is characterised by progressive changes of the lung architecture causing cough and dyspnoe …
Blood Biomarkers in Idiopathic Pulmonary Fibrosis.
Guiot J, Moermans C, Henket M, Corhay JL, Louis R. Guiot J, et al. Lung. 2017 Jun;195(3):273-280. doi: 10.1007/s00408-017-9993-5. Epub 2017 Mar 28. Lung. 2017. PMID: 28353114 Free PMC article. Review.
PURPOSE: Idiopathic pulmonary fibrosis (IPF) is a progressive and lethal lung disease of unknown origin whose incidence has been increasing over the latest decade partly as a consequence of population ageing. ...Up to now, though several interesting candidates are p …
PURPOSE: Idiopathic pulmonary fibrosis (IPF) is a progressive and lethal lung disease of unknown origin whose incidence has be …
11,437 results
You have reached the last available page of results. Please see the User Guide for more information.